Aussie brand Savvy Beverage has called out what it believes is the prevalence of highly priced functional beverages that contain inadequate beneficial ingredients, imploring greater honesty and transparency among companies to advance the emerging category....
After 25 years playing a pivotal role in the evolution of Australia's thriving supplements sector, Ian Chant was recognised for his long-standing industry support at the Complementary Medicines Australia Awards in December, before reflecting on the...
A new review by Australia-based researchers suggests there is a shortage of proven and reliable microbiome-based interventions for allergic disorders. Writing in the World Allergy Organization Journal, the scientists connect this to the interaction between...
Nutraceutical start-ups should “learn to say no” to questionable retail strategies and “know where their boundaries are” as they seek to grow the distribution of their products, says Renovatio Bioscience’s founder Dr Vincent Candrawinata in the first...
China’s recent removal of tariffs on all dairy products from New Zealand, including milk powder used for both general consumption and processing to infant formula, could spell huge potential for brands that have a strong focus on quality and sustainability.
Food Standards Australia New Zealand (FSANZ) has approved dsm-firmenich’s four human milk oligosaccharides (HMOs), including the mixture of 2’-fucosyllactose (2’-FL) and difucosyllactose (DFL), for use in infant formula products.
Australian infant goat milk formula specialist Nuchev is launching its first bovine product for older children and adults as it looks to introduce a series of products aimed at enhancing digestion and immunity over the next 12 months.
Experts from the New Zealand food and beverage industry and academia have expressed mixed reactions to Fonterra’s recently-announced Climate Roadmap, simultaneously urging for farmer-level collaboration to be prioritised over novel tech.
A new study suggests that Gencor Pacific’s Levagen+ Palmitoylethanolamide (PEA) ingredient may alleviate symptoms of seasonal allergies as shown by a reduction in histamine and inflammatory markers despite a strong placebo effect.
The three-year transition period for sports nutrition products, such as those that make therapeutic claims and come in a tablet form, to complete their registration as therapeutic goods in Australia is coming to an end.
Probiotic BG01-4 improves specific symptoms of constipation and related GI dysfunction in people with self-reported functional gastrointestinal disorders (FGID), which affects a significant percentage of the global population, a new study concludes.
Australia’s Kommunity Brew believes that hemp has the potential to feature more widely in its NPD and innovation strategies, amidst the addition of more local acquisitions to its healthier beverage portfolio.
New Zealand researchers are beginning a six-month study in Auckland exploring feijoa powder’s ability to prevent diabetes, and says that health claim would support the country’s export ambitions in Asia for the backyard staple.
New Zealand-based FMCG company Red Shoots says consumers are increasingly looking for products with functional benefits in supermarkets, which has sparked partnership opportunities with major retailers.
Precision probiotics firm Biome Australia says that giving practitioners a foundational understanding of microbiome modulation, before reinforcing efficacy via clinical trials, will be key to its ongoing growth objectives in the market.
A correlation between curcumin, turmeric consumption and liver injury risk does not imply causation, trade body Complementary Medicines Australia (CMA) has pointed out, in response to reports on how the ingredient could have been linked to a fatal outcome.
There are few bigger industry buzzwords these days than sustainability, but one small New Zealand therapeutic oils firm can boast an impressive track record spanning more than three decades, having embarked on its mission ‘before sustainability was even...
New Zealand’s Alps 2 Ocean Foods is launching a protein-rich and nutrient-fortified beef bar made from male calves that are otherwise killed shortly after birth or made into lower-value ground beef – a move that the firm believes is more sustainable for...
New Zealand mead brand Lone Bee is hoping to strengthen its exports to South East Asia by entering a major supermarket, and is on the lookout for regional partners for potential new flavour collaborations.
Fonterra says the microbiome is increasingly taking the centre stage when it comes to human health, with its new nutrition science venture arm identifying China and US as key investment targets for personalised solutions.
Both New Zealand’s natural health product industry body and several opposition members of parliament have voiced concerns over the Therapeutic Products Bill, which will regulate natural health products in the country.
A five-year long trial from Australia has shown that taking large amounts of vitamin D at 60,000 IU each month will not affect the gut microbiota – a result that is in contrary to findings from a number of previous studies.
Industry body Natural Health Products New Zealand (NHPNZ) has welcomed changes that the government has made to the Therapeutic Products Bill post public consultation, but believes that more needs to be done, such as changing the product authorisation...
The natural health products sector in New Zealand is hoping that lightning doesn’t strike twice and its lengthy campaign for an updated regulatory regime isn’t once again derailed by a forthcoming general election.
New Zealand biotech firm NewFish is looking to accelerate the development and commercialisation of microalgae-based products through strategic partnerships, with the ambition of creating a “whole new category” in the future.
New Zealand biotech firm SRW is capitalising on global partnerships to stretch the R&D and NPD potential in the healthy ageing space, and says growing APAC demand is coming from China and South East Asia.
New Zealand’s consumer watchdog has published data showing that 80% of those surveyed had taken a supplement in the last year, but doubts over the regulatory regime and its future persist among industry and consumers.